Acadia Healthcare (ACHC) Rating Increased to Hold at ValuEngine

ValuEngine upgraded shares of Acadia Healthcare (NASDAQ:ACHC) from a sell rating to a hold rating in a report published on Friday morning.

Other research analysts have also recently issued research reports about the stock. Jefferies Financial Group lifted their price target on shares of Acadia Healthcare from $44.00 to $47.00 and gave the stock a buy rating in a research note on Tuesday, July 31st. BMO Capital Markets cut shares of Acadia Healthcare from an outperform rating to a market perform rating and set a $45.00 target price on the stock. in a research note on Wednesday, August 1st. BidaskClub upgraded shares of Acadia Healthcare from a hold rating to a buy rating in a research note on Thursday, September 6th. Credit Suisse Group lifted their target price on shares of Acadia Healthcare from $40.00 to $44.00 and gave the company a neutral rating in a research note on Tuesday, July 31st. Finally, Zacks Investment Research upgraded shares of Acadia Healthcare from a hold rating to a buy rating and set a $48.00 target price on the stock in a research note on Tuesday, July 24th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. Acadia Healthcare currently has a consensus rating of Hold and an average price target of $43.11.

Shares of Acadia Healthcare stock traded up $0.92 on Friday, hitting $39.50. 2,905,140 shares of the company’s stock were exchanged, compared to its average volume of 2,791,010. The stock has a market capitalization of $3.41 billion, a PE ratio of 17.17, a P/E/G ratio of 1.38 and a beta of 0.63. Acadia Healthcare has a 1 year low of $26.92 and a 1 year high of $45.02. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24.



Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Monday, July 30th. The company reported $0.70 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.70. The business had revenue of $765.70 million for the quarter, compared to analysts’ expectations of $767.93 million. Acadia Healthcare had a net margin of 7.52% and a return on equity of 7.93%. The company’s revenue was up 5.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.66 EPS. As a group, research analysts anticipate that Acadia Healthcare will post 2.52 EPS for the current year.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Alpine Woods Capital Investors LLC purchased a new position in shares of Acadia Healthcare during the 2nd quarter valued at $153,000. New Jersey Better Educational Savings Trust purchased a new stake in Acadia Healthcare in the 2nd quarter worth $205,000. Cubist Systematic Strategies LLC purchased a new stake in Acadia Healthcare in the 1st quarter worth $255,000. Bbva Compass Bancshares Inc. purchased a new stake in Acadia Healthcare in the 2nd quarter worth $259,000. Finally, Strs Ohio purchased a new stake in Acadia Healthcare in the 3rd quarter worth $308,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

See Also: How Investors Use a Balance Sheet

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply